Adamis Pharmaceuticals Corp·4

Aug 17, 5:30 PM ET

Adamis Pharmaceuticals Corp 4

4 · Adamis Pharmaceuticals Corp · Filed Aug 17, 2015

Insider Transaction Report

Form 4
Period: 2015-08-13
Transactions
  • Purchase

    Common Stock

    2015-08-13$3.26/sh+9,800$31,93039,918 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.28, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Documents

1 file
  • 4
    william-form4_081315.xmlPrimary

    OWNERSHIP DOCUMENT